Meta Pixel

News and Announcements

The Great Re-Allocation: Why AI is Forcing Smart Money From Software to Hard Science

  • Published November 18, 2025 5:59AM UTC
  • Publisher Steve Torso
  • Categories Capital Insights, Landing, Trending

Smart money is quietly shifting its thesis from software to hard science. This is not a temporary trend. It is a foundational shift in how “defensibility” is being valued, and it is happening with unprecedented speed.

In recent conversations, I am hearing the same challenge from high-net-worth investors and family offices: it is becoming incredibly difficult to build a confident investment thesis around software.

The reason is simple. AI is aggressively commoditising the sector. The old barriers to entry, like complex codebases and distribution networks, are disappearing.

The Dual Squeeze on Investors

Investors are being squeezed from two directions at once.

First, as AI commoditises pure software plays, the traditional moats are evaporating. It is difficult to justify a high valuation for a business whose core function could be replicated by a more advanced AI model tomorrow.

Second, the AI race itself is consolidating. The winners are emerging faster than in any previous tech cycle. These “runaway” companies are consolidating talent, data, and compute power, creating a breakaway effect.

Access to these proprietary, high-growth deals is narrowing rapidly. These companies are not doing wide roadshows. They are locking in strategic capital from partners who were in the room before the breakaway, making it difficult for most investors to get in.

The Pivot to “Real” Moats

This dual pressure is forcing a necessary pivot. We are seeing capital flow away from pure software and move decisively towards technical and hard-science opportunities.

Why? Because these businesses have obvious, durable defensive moats.

You cannot commoditise a specific regulatory process.

You cannot use AI to bypass physics.

You cannot replicate a biological asset or a patented chemical compound.

These natural barriers are not subject to the same disruptive forces as code. They create a much clearer, more understandable pathway to value creation.

In this new paradigm, AI’s role shifts. It is no longer the product itself. It becomes a powerful accelerant for solving fundamental technical challenges. It is the tool that helps a deep tech company solve physics or biology problems faster, cheaper, and more effectively than ever before.

This is the new thesis. The clearest opportunities are no longer in the businesses AI is replacing, but in the complex, real-world sectors that AI can accelerate. This is a foundational shift, and it will define the next decade of wealth creation.

Capital Insights
The Ferrari of Immunotherapy: Chimeric’s High-Stakes Race to Cure Cancer

In the high-stakes world of biotechnology, the most sophisticated weapon against cancer isn’t a new chemical compound but the patient’s own immune system, re-engineered with the precision of a high-performance engine. “This particular CAR T is like a Ferrari,” says Dr. Rebecca McQualter, CEO of Chimeric Therapeutics (ASX: CHM). “It’s got two big engines on […]

Capital Insights
From Algae Pioneers to a Natural Revolution: The Second Act of WRS Bioproducts

As the US FDA prepares to phase out synthetic food colors by the end of 2026, WRS Bioproducts is stepping in to solve a looming supply crisis. Led by industry pioneer Harry Rosen, the company is leveraging 40 years of industrial algae farming expertise to scale production of natural, superior-quality beta-carotene, positioning itself as a vital supplier in the rapidly shifting global market for natural ingredients.

Join over 45,000+ sophisticated investors

Join Now